SHAZ Soars 53.6% on AI Capacity Surge; SNDK, ACB Rally on EPS Revisions
SHAZ jumped 53.6% to $76.46 after its EPS growth estimate hit 86.2%, fueled by an AI capacity surge to 212MW and a $4.9B NVIDIA deal. SNDK gained 35.4% to $1641.11 on a 25.6% EPS growth estimate, with JPMorgan bullishness outweighing caution. ACB rose 23.5% to $3.68 after its EPS growth estimate jumped 16.1pp to 107.5%.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| SHAZ | Technology | 2026-08-07 | N/A | +53.6% |
| SNDK | Technology | 2026-08-07 | N/A | +35.4% |
| MYO | Healthcare | 2026-08-06 | N/A | +31.3% |
| NYXH | Healthcare | 2026-08-06 | +7.0pp | +23.7% |
| ACB | Healthcare | 2026-08-06 | +16.1pp | +23.5% |
Why did SHAZ stock jump in August 2026?
SHAZ jumped 53.6% from $49.79 to $76.46 after analysts raised its forward EPS growth estimate to 86.2% on August 7.
The catalyst: Q2 earnings revealed AI capacity surged to 212MW (from 132MW) and a $4.9B six-year NVIDIA compute collaboration, securing a guaranteed minimum revenue stream. With a contracted revenue book of $8.8B YTD and record pricing above $4 per GPU hour, the EPS revision was validated by fundamentals, making the 53.6% move a market repricing of growth.
SHAZ EPS revision history → · Screener snapshot from 2026-08-07 →
FAQ: SHAZ
Why did SHAZ stock jump in August 2026?
SHAZ jumped 53.6% to $76.46 after its EPS growth estimate was revised to 86.2%, driven by a 212MW AI capacity surge and a $4.9B NVIDIA deal.
Is SHAZ a buy after the rally?
SHAZ's EPS growth estimate of 86.2% and $8.8B contracted revenue suggest strong momentum, but revenue recognition lags until Q4 2026, so execution risks remain.
What caused SHAZ's surge?
The surge was caused by a positive EPS revision to 86.2% following Q2 earnings that showed AI capacity doubling and a $4.9B NVIDIA collaboration.
Why did SNDK stock jump in August 2026?
SNDK jumped 35.4% from $1212.21 to $1641.11 after analysts raised its forward EPS growth estimate to 25.6% on August 7.
The move was reinforced by JPMorgan seeing further upside for SanDisk, even as some analysts warned of a short-covering bounce after July's 58% drop. Despite caution from Great Hill Capital, the EPS revision and AI expansion narrative drove the stock to top the S&P 500 on August 14.
SNDK EPS revision history → · Screener snapshot from 2026-08-07 →
FAQ: SNDK
Why did SNDK stock jump?
SNDK jumped 35.4% to $1641.11 after its EPS growth estimate was revised to 25.6%, with JPMorgan adding bullish support on AI expansion.
Is SNDK a buy after the rally?
SNDK's 25.6% EPS growth estimate and JPMorgan's upside view support buying, but some analysts warn the rally may be a short-covering bounce after July's 58% drop.
What is SNDK's EPS growth estimate?
SNDK's EPS growth estimate for next year is 25.6%, which was revised upward on August 7, 2026.
Why did MYO stock jump in August 2026?
MYO jumped 31.3% from $1.31 to $1.72 after analysts raised its forward EPS growth estimate to 27.8% on August 6.
With no major earnings news in the window, the move was driven by the positive estimate revision, likely reflecting improved fundamentals in the healthcare technology space. The stock's gain signals that even small-cap healthcare names are benefiting from EPS-driven buying.
MYO EPS revision history → · Screener snapshot from 2026-08-06 →
FAQ: MYO
Why did MYO stock jump?
MYO jumped 31.3% to $1.72 after its EPS growth estimate was revised to 27.8% on August 6, with no major news catalyst.
What is MYO's EPS growth estimate?
MYO's EPS growth estimate for next year is 27.8%, revised upward on August 6, 2026.
Is MYO a buy after the rally?
MYO's 27.8% EPS growth estimate suggests positive momentum, but the lack of news means investors should watch for earnings confirmation.
Why did NYXH stock jump in August 2026?
NYXH jumped 23.7% from $1.31 to $1.62 after analysts raised its forward EPS growth estimate by 7.0 percentage points to 34.8% on August 6.
The absence of earnings news suggests the move was purely EPS-revision driven, reflecting improved profitability expectations for Nyxoah. This aligns with a broader uptick in healthcare stocks where estimate revisions are the primary catalyst.
NYXH EPS revision history → · Screener snapshot from 2026-08-06 →
FAQ: NYXH
Why did NYXH stock jump?
NYXH jumped 23.7% to $1.62 after its EPS growth estimate was revised up 7.0pp to 34.8% on August 6, with no news catalyst.
What is NYXH's EPS growth estimate?
NYXH's EPS growth estimate for next year is 34.8%, up from 27.8% after the August 6 revision.
Is NYXH a buy after the rally?
NYXH's 34.8% EPS growth estimate and no negative news make it a potential buy, but investors should monitor execution.
Why did ACB stock jump in August 2026?
ACB jumped 23.5% from $2.98 to $3.68 after analysts raised its forward EPS growth estimate by 16.1pp to 107.5% on August 6.
The move was reinforced by the August 10 annual meeting results, where shareholders approved say-on-pay with 82.97% support, signaling confidence in the medical-first strategy. This EPS revision, combined with positive governance news, drove the gain.
ACB EPS revision history → · Screener snapshot from 2026-08-06 →
FAQ: ACB
Why did ACB stock jump?
ACB jumped 23.5% to $3.68 after its EPS growth estimate was revised up 16.1pp to 107.5% on August 6, with shareholder meeting support as a catalyst.
What is ACB's EPS growth estimate?
ACB's EPS growth estimate for next year is 107.5%, up from 91.5% after the August 6 revision.
Is ACB a buy after the rally?
ACB's strong EPS growth estimate of 107.5% and shareholder approval suggest buying, but medical cannabis execution remains key.
Today's performers signal that EPS revisions remain a powerful driver, especially when backed by strong fundamentals like AI capacity growth or shareholder confidence. The market is rewarding companies with upward estimate momentum, even amid sector volatility.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →